Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Benedikt Bernd Claus, Michael Specka, Heath MacAnally, Norbert Scherbaum, Fabrizio Schifano, Udo Bonnet

Research output: Contribution to journalArticlepeer-review

11 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?'. Together they form a unique fingerprint.

Medicine & Life Sciences